PL1986606T3 - Ciekłe formulacje zawierające fenylefrynę - Google Patents
Ciekłe formulacje zawierające fenylefrynęInfo
- Publication number
- PL1986606T3 PL1986606T3 PL07751095T PL07751095T PL1986606T3 PL 1986606 T3 PL1986606 T3 PL 1986606T3 PL 07751095 T PL07751095 T PL 07751095T PL 07751095 T PL07751095 T PL 07751095T PL 1986606 T3 PL1986606 T3 PL 1986606T3
- Authority
- PL
- Poland
- Prior art keywords
- phenylephrine
- containing liquid
- liquid formulations
- formulations
- liquid
- Prior art date
Links
- 239000012669 liquid formulation Substances 0.000 title 1
- SONNWYBIRXJNDC-VIFPVBQESA-N phenylephrine Chemical compound CNC[C@H](O)C1=CC=CC(O)=C1 SONNWYBIRXJNDC-VIFPVBQESA-N 0.000 title 1
- 229960001802 phenylephrine Drugs 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Emergency Medicine (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US77463406P | 2006-02-21 | 2006-02-21 | |
| EP07751095.6A EP1986606B1 (en) | 2006-02-21 | 2007-02-16 | Phenylephrine-containing liquid formulations |
| PCT/US2007/004310 WO2007098128A2 (en) | 2006-02-21 | 2007-02-16 | Phenylephrine-containing liquid formulations |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL1986606T3 true PL1986606T3 (pl) | 2019-08-30 |
Family
ID=38283964
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL07751095T PL1986606T3 (pl) | 2006-02-21 | 2007-02-16 | Ciekłe formulacje zawierające fenylefrynę |
| PL10188391T PL2316425T3 (pl) | 2006-02-21 | 2007-02-16 | Ciekłe formulacje zawierąjące składnik aktywny, glicerynę i sorbitol |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL10188391T PL2316425T3 (pl) | 2006-02-21 | 2007-02-16 | Ciekłe formulacje zawierąjące składnik aktywny, glicerynę i sorbitol |
Country Status (12)
| Country | Link |
|---|---|
| US (4) | US8940796B2 (pl) |
| EP (2) | EP2316425B1 (pl) |
| AU (1) | AU2007217799B2 (pl) |
| CA (1) | CA2642048C (pl) |
| ES (2) | ES2728823T3 (pl) |
| HU (2) | HUE043620T2 (pl) |
| PE (2) | PE20071310A1 (pl) |
| PL (2) | PL1986606T3 (pl) |
| PT (2) | PT1986606T (pl) |
| TR (2) | TR201815803T4 (pl) |
| TW (1) | TWI482620B (pl) |
| WO (1) | WO2007098128A2 (pl) |
Families Citing this family (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8940796B2 (en) | 2006-02-21 | 2015-01-27 | Wyeth Llc | Phenylephrine liquid formulations |
| US20070249727A1 (en) | 2006-04-21 | 2007-10-25 | The Proctor & Gamble Company | Compositions and kits useful for treatment of respiratory illness |
| US10022339B2 (en) * | 2006-04-21 | 2018-07-17 | The Procter & Gamble Company | Compositions and methods useful for treatment of respiratory illness |
| US20070254027A1 (en) | 2006-04-28 | 2007-11-01 | The Procter & Gamble Company | Compositions and methods useful for treatment of respiratory illness |
| CA2653950A1 (en) * | 2006-06-01 | 2007-12-13 | Schering Corporation | Phenylephrine pulsed release formulations and pharmaceutical compositions |
| JP5121824B2 (ja) * | 2006-06-01 | 2013-01-16 | メルク・シャープ・アンド・ドーム・コーポレーション | フェニレフリンの徐放のための薬学的組成物 |
| CN104161736A (zh) * | 2006-06-01 | 2014-11-26 | Msd消费保健品公司 | 包含去氧肾上腺素的缓释药物制剂 |
| NZ573174A (en) * | 2006-06-01 | 2012-01-12 | Msd Consumer Care Inc | Sustained release pharmaceutical dosage form containing phenylephrine |
| MX2009013054A (es) * | 2007-06-01 | 2010-01-15 | Schering Plough Healthcare | Composicion farmaceutica que comprende un sustrato y un revestimiento que contiene un ingrediente activo y alcohol polivinilico. |
| PE20091084A1 (es) * | 2007-12-07 | 2009-07-23 | Schering Plough Healthcare | Formulaciones farmaceuticas de fenilefrina y composiciones para absorcion transmucosal |
| AU2014306759B2 (en) | 2013-08-12 | 2018-04-26 | Pharmaceutical Manufacturing Research Services, Inc. | Extruded immediate release abuse deterrent pill |
| US9492444B2 (en) | 2013-12-17 | 2016-11-15 | Pharmaceutical Manufacturing Research Services, Inc. | Extruded extended release abuse deterrent pill |
| US10172797B2 (en) | 2013-12-17 | 2019-01-08 | Pharmaceutical Manufacturing Research Services, Inc. | Extruded extended release abuse deterrent pill |
| WO2015137829A1 (en) * | 2014-03-12 | 2015-09-17 | Angeles Relinda G | Stable and palatable liquid pharmaceutical composition of phenylephrine and a maleate salt of an antihistamine |
| EP3169315B1 (en) | 2014-07-17 | 2020-06-24 | Pharmaceutical Manufacturing Research Services, Inc. | Immediate release abuse deterrent liquid fill dosage form |
| US20160106737A1 (en) | 2014-10-20 | 2016-04-21 | Pharmaceutical Manufacturing Research Services, Inc. | Extended Release Abuse Deterrent Liquid Fill Dosage Form |
| CN104922124B (zh) * | 2015-05-28 | 2017-06-30 | 华润三九医药股份有限公司 | 一种肾素那敏片及其制备方法 |
| CN104983732B (zh) * | 2015-05-28 | 2018-05-04 | 华润三九医药股份有限公司 | 一种布洛肾素那敏片及其制备方法 |
| EP3820440A1 (en) * | 2018-07-09 | 2021-05-19 | Bayer HealthCare, LLC | An aqueous-based composition containing xantan gum as inhibitor of microbial growth |
| CN109125257B (zh) * | 2018-10-18 | 2020-12-01 | 云南大唐汉方制药股份有限公司 | 氨酚愈创肾素口服液及其制备方法 |
| CN109045003B (zh) * | 2018-10-18 | 2020-12-01 | 云南大唐汉方制药股份有限公司 | 氨酚拉明肾素口服液及其制备方法 |
| CN109044968B (zh) * | 2018-10-18 | 2020-12-01 | 云南大唐汉方制药股份有限公司 | 氨酚右美肾素口服液及其制备方法 |
| US12539314B1 (en) * | 2019-03-07 | 2026-02-03 | Genus Lifesciences Inc. | Aqueous oral compositions including potassium chloride |
| CN110327339A (zh) * | 2019-08-07 | 2019-10-15 | 北京博达绿洲医药科技研究有限公司 | 一种复方右美沙芬口服溶液及其制备方法和用途 |
| CN110507607A (zh) * | 2019-09-27 | 2019-11-29 | 葵花药业集团北京药物研究院有限公司 | 苯海拉明肾素口服液及其制备方法和用途 |
| MA58173B1 (fr) | 2019-12-23 | 2024-03-29 | Nutra Essential Otc S L | Composition liquide comprenant de l'ibuprofène et de la phényléphrine |
| WO2021150747A1 (en) * | 2020-01-22 | 2021-07-29 | Nevakar Inc. | Phenylephrine hydrochloride compositions and containers |
| CN111450051B (zh) * | 2020-04-21 | 2022-03-18 | 武汉贝参药业股份有限公司 | 一种富马酸酮替芬口服溶液的制备方法 |
| CN112076183A (zh) * | 2020-08-28 | 2020-12-15 | 北京博达绿洲医药科技研究有限公司 | 包含盐酸去氧肾上腺素液体组合物 |
| CN112402416A (zh) * | 2020-12-18 | 2021-02-26 | 北京博达绿洲医药科技研究有限公司 | 一种治疗感冒的复方液体制剂及其制备方法 |
| CN113081958B (zh) * | 2021-05-01 | 2022-05-03 | 安徽新世纪药业有限公司 | 一种地氯雷他定口服溶液及其制备方法 |
Family Cites Families (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3515781A (en) | 1967-10-12 | 1970-06-02 | Johnson & Johnson | Cold capsule |
| AU670567B2 (en) | 1992-03-05 | 1996-07-25 | American Home Products Corporation | Pharmaceutical coated cores |
| US5405604A (en) * | 1992-10-16 | 1995-04-11 | The Procter & Gamble Company | Concentrated mouthrinse for efficient delivery of antimicrobials |
| CA2172807C (en) | 1994-08-01 | 1999-10-12 | Keith S. Lienhop | Tastemasked liquid pharmaceutical delivery system |
| US5616621A (en) | 1995-01-30 | 1997-04-01 | American Home Products Corporation | Taste masking liquids |
| US5759579A (en) | 1996-12-05 | 1998-06-02 | American Home Products Corporation | Pharmaceutical suspension systems |
| DE69815003T2 (de) * | 1997-09-10 | 2004-04-01 | Takeda Chemical Industries, Ltd. | Stabilisierte pharmazeutische Zusammensetzung |
| US20010053775A1 (en) * | 1998-01-30 | 2001-12-20 | Matthias Seidel | Nasal solutions |
| DE69901936T2 (de) * | 1998-01-30 | 2002-11-28 | Novartis Consumer Health S.A., Nyon | Nasale lösungen |
| US20040234457A1 (en) * | 1999-10-19 | 2004-11-25 | The Procter & Gamble Company | Methods of preventing and treating SARS using low pH respiratory tract compositions |
| WO2003011306A1 (en) * | 2001-07-31 | 2003-02-13 | Wyeth | Sucralose formulations to mask unpleasant tastes |
| US6462094B1 (en) * | 2001-08-22 | 2002-10-08 | Medpointe Healthcare Inc. | Decongestant/expectorant compositions |
| US6509492B1 (en) | 2001-08-31 | 2003-01-21 | First Horizon Pharmaceutical Corporation | Tannate compositions and methods of treatment |
| US20030060422A1 (en) | 2001-08-31 | 2003-03-27 | Balaji Venkataraman | Tannate compositions and methods of treatment |
| US7101572B2 (en) * | 2001-12-07 | 2006-09-05 | Unilab Pharmatech, Ltd. | Taste masked aqueous liquid pharmaceutical composition |
| US20050266032A1 (en) * | 2003-12-17 | 2005-12-01 | Sovereign Pharmaceuticals, Ltd. | Dosage form containing multiple drugs |
| AU2005205933B2 (en) * | 2004-01-21 | 2010-02-18 | Elanco Animal Health Ireland Limited | Mitratapide oral solution |
| US20050266031A1 (en) * | 2004-05-25 | 2005-12-01 | Jay Dickerson | Pharmaceutical suspension composition |
| WO2006022996A2 (en) * | 2004-08-04 | 2006-03-02 | Sovereign Pharmaceuticals, Ltd. | Dosage form containing multiple drugs |
| AU2005315291A1 (en) | 2004-12-13 | 2006-06-22 | Mcneil-Ppc, Inc. | Compositions and methods for stabilizing active pharmaceutical ingredients |
| US20070160689A1 (en) | 2006-01-12 | 2007-07-12 | Everett Laboratories, Inc. | Compositions and methods for treatment of coughing, sneezing, rhinorrhea, and/or nasal obstruction |
| US8940796B2 (en) | 2006-02-21 | 2015-01-27 | Wyeth Llc | Phenylephrine liquid formulations |
| US20070254027A1 (en) * | 2006-04-28 | 2007-11-01 | The Procter & Gamble Company | Compositions and methods useful for treatment of respiratory illness |
| CA2653950A1 (en) | 2006-06-01 | 2007-12-13 | Schering Corporation | Phenylephrine pulsed release formulations and pharmaceutical compositions |
-
2007
- 2007-02-09 US US11/704,407 patent/US8940796B2/en active Active
- 2007-02-16 PL PL07751095T patent/PL1986606T3/pl unknown
- 2007-02-16 PL PL10188391T patent/PL2316425T3/pl unknown
- 2007-02-16 WO PCT/US2007/004310 patent/WO2007098128A2/en not_active Ceased
- 2007-02-16 PT PT07751095T patent/PT1986606T/pt unknown
- 2007-02-16 HU HUE07751095A patent/HUE043620T2/hu unknown
- 2007-02-16 PT PT10188391T patent/PT2316425T/pt unknown
- 2007-02-16 HU HUE10188391A patent/HUE039382T2/hu unknown
- 2007-02-16 TR TR2018/15803T patent/TR201815803T4/tr unknown
- 2007-02-16 ES ES07751095T patent/ES2728823T3/es active Active
- 2007-02-16 AU AU2007217799A patent/AU2007217799B2/en active Active
- 2007-02-16 TW TW096106194A patent/TWI482620B/zh active
- 2007-02-16 TR TR2019/06970T patent/TR201906970T4/tr unknown
- 2007-02-16 EP EP10188391.6A patent/EP2316425B1/en active Active
- 2007-02-16 ES ES10188391.6T patent/ES2692890T3/es active Active
- 2007-02-16 CA CA2642048A patent/CA2642048C/en active Active
- 2007-02-16 EP EP07751095.6A patent/EP1986606B1/en active Active
- 2007-02-20 PE PE2007000185A patent/PE20071310A1/es not_active Application Discontinuation
- 2007-02-20 PE PE2010001013A patent/PE20110010A1/es not_active Application Discontinuation
-
2014
- 2014-12-12 US US14/568,734 patent/US9801941B2/en active Active
-
2017
- 2017-07-19 US US15/653,675 patent/US11419938B2/en active Active
-
2019
- 2019-03-12 US US16/299,643 patent/US11406712B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| EP2316425B1 (en) | 2018-08-29 |
| EP2316425A1 (en) | 2011-05-04 |
| US20170333561A1 (en) | 2017-11-23 |
| WO2007098128A2 (en) | 2007-08-30 |
| TW200800143A (en) | 2008-01-01 |
| HUE039382T2 (hu) | 2018-12-28 |
| US20070197661A1 (en) | 2007-08-23 |
| US20150150976A1 (en) | 2015-06-04 |
| EP1986606A2 (en) | 2008-11-05 |
| PE20071310A1 (es) | 2007-12-12 |
| US11419938B2 (en) | 2022-08-23 |
| CA2642048C (en) | 2015-11-24 |
| ES2692890T3 (es) | 2018-12-05 |
| PE20110010A1 (es) | 2011-01-12 |
| TR201815803T4 (tr) | 2018-11-21 |
| US11406712B2 (en) | 2022-08-09 |
| EP1986606B1 (en) | 2019-04-10 |
| AU2007217799B2 (en) | 2012-12-13 |
| PT2316425T (pt) | 2018-11-13 |
| US20190209688A1 (en) | 2019-07-11 |
| AU2007217799A1 (en) | 2007-08-30 |
| HUE043620T2 (hu) | 2019-08-28 |
| TWI482620B (zh) | 2015-05-01 |
| ES2728823T3 (es) | 2019-10-28 |
| TR201906970T4 (tr) | 2019-06-21 |
| WO2007098128A3 (en) | 2007-10-11 |
| US8940796B2 (en) | 2015-01-27 |
| PT1986606T (pt) | 2019-06-12 |
| PL2316425T3 (pl) | 2019-01-31 |
| CA2642048A1 (en) | 2007-08-30 |
| US9801941B2 (en) | 2017-10-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUE043620T2 (hu) | Fenilefrin-tartalmú folyadékkészítmények | |
| GB2435419B (en) | Formulations | |
| IL188915A0 (en) | Liquid formulations | |
| EP2046930A4 (en) | FORMULATIONS BASED ON RHAMNOLIPIDS | |
| GB0608098D0 (en) | Formulation | |
| PL3329912T3 (pl) | Ciekła kompozycja | |
| GB0711656D0 (en) | Formulations | |
| PL2789349T3 (pl) | Ciekły preparat zawierający pimobendan | |
| IL205105A0 (en) | Lh liquid formulations | |
| EP1996034A4 (en) | WATER FORMULATION | |
| EP1977733A4 (en) | LIQUID COSMETICS | |
| GB0718409D0 (en) | Formulations | |
| GB0605780D0 (en) | Formulations | |
| GB0711957D0 (en) | Formulations | |
| GB0710899D0 (en) | Formulations | |
| GB0610336D0 (en) | Formulations | |
| GB0615108D0 (en) | Novel formulations | |
| GB0625095D0 (en) | Formulation | |
| GB0625312D0 (en) | Formulation | |
| GB0718404D0 (en) | Formulations | |
| EP1951258A4 (en) | LIQUID FORMULATIONS | |
| GB0612809D0 (en) | Formulation | |
| IL176030A0 (en) | Liquid colander-ladle | |
| ZA200807682B (en) | Novel formulations | |
| GB0705179D0 (en) | Formulations |